UCLA Reverses Liver Disease by Removing "Zombie" Cells

Imagine if you could reverse liver damage without changing your diet. UCLA scientists just did exactly that in mice by removing a surprising culprit: immune cells that refuse to die.

These "zombie" immune cells accumulate in aging tissues, especially in diseased livers. They don't divide and they won't die, but they flood surrounding tissue with inflammatory signals that cause serious damage.

Anthony Covarrubias, who led the research at UCLA's Broad Center of Regenerative Medicine, compares them to stalled cars on a busy freeway. "Just one stalled car can back up traffic for miles," he said. "That's what these cells do to a tissue: even a small number causes enormous disruption."

The team solved a mystery that stumped researchers for years. Scientists weren't sure if macrophages, the immune cells that clean up cellular debris, could actually become senescent. The UCLA researchers identified a molecular signature that clearly marks these dysfunctional cells.

What they found was startling. In young mice, only 5% of liver immune cells were senescent. In older mice, that number jumped to 60-80%, matching the rise in chronic inflammation.

The researchers discovered that excess cholesterol pushes healthy immune cells into this zombie state. When they exposed normal macrophages to high LDL cholesterol in the lab, the cells stopped dividing and started pumping out inflammatory proteins.

"Physiologically, macrophages can handle cholesterol metabolism," said Ivan Salladay-Perez, the study's first author. "But in a chronic state, it's pathological."

Then came the breakthrough. When scientists treated mice with a drug that selectively eliminated senescent cells, the results were dramatic. Liver size dropped from 7% of body weight to a healthy 4-5%. The mice lost about 25% of their body weight, and their livers transformed from enlarged and yellowish to smaller and healthy red.

The mice kept eating the same high-fat, high-cholesterol diet. "That's what wowed me," said Salladay-Perez. "Eliminating senescent cells doesn't just slow the fatty liver. It actually reverses it."

The Ripple Effect

The findings extend far beyond the laboratory. When researchers analyzed human liver biopsies, they found the same zombie cell signature in diseased livers compared to healthy ones.

This matters especially in Los Angeles, where 30-40% of residents have fatty liver disease, with even higher rates in Latino communities. The condition is appearing in younger and younger people, yet treatment options remain limited.

"This is a huge public health crisis in the making," said Covarrubias, who is also an assistant professor at UCLA. "We're really happy to make some inroads into understanding what's driving it."

The drug used in the study is too toxic for humans, but the team is now screening for safer alternatives. If successful, this approach could treat not just liver disease but potentially slow biological aging in the brain, heart, and other organs where these zombie cells accumulate.

A future where we can reverse organ damage, published in Nature Aging, just moved closer to reality.